Related by context. All words. (Click for frequent words.) 78 GVAX ® 76 kidney urologic 75 pharmacogenomic translational research 74 gastro intestinal inflammation 74 Prodarsan R 74 oncolytic virus therapies 73 novel immunotherapies 73 adrenergic regulation 73 PI3K/Akt pathway inhibitor 72 AAG geldanamycin analog 72 Nasdaq IDIX biopharmaceutical 72 DPX Survivac 72 tramiprosate Alzhemed TM 72 humanised monoclonal antibody 72 HuMax TAC 72 oral ghrelin agonist 72 humanized therapeutic 72 Kosan dependence 72 Crofelemer budesonide foam 72 commercialize deforolimus 71 novel peptides 71 immunotherapeutic approaches 71 commercialize CorMedix drug 71 AKT inhibitor 71 OncoVex 71 progressive metastatic prostate 71 ZFP Therapeutics 71 pralatrexate injection folate analogue 71 Sphingomab TM 71 personalized cellular immunotherapy 71 immunologic diseases 71 NS5b 71 including eniluracil ADH 71 PF # [002] 71 SinuNase ™ 71 ALTROPANE R 71 human IgG1 monoclonal 71 CYT# potent vascular disrupting 71 vaccine GMK 71 fusion enhancers 71 immunotherapeutic vaccine 71 Selective Electrochemical Tumor Ablation 71 molecular therapeutics immunotherapies 71 XL# anticancer compounds 71 Bayer HealthCare Onyx Pharmaceuticals 71 TransVax ™ 71 neurology immunology 70 Immunotherapeutic 70 Reports Preclinical Data 70 vaccines oncolytic virus 70 oral prodrug 70 Evoltra ® 70 RNA antagonists 70 Tarvacin Anti Cancer 70 therapeutic monoclonal antibody 70 GVAX R 70 proprietary radiolabeled monoclonal 70 MKC# MT 70 midstage clinical 70 rotavirus shingles 70 Initiates Enrollment 70 Nanobody R 70 candidate deforolimus 70 OTCBB URGP specialty 70 telomerase therapeutic 70 molecular imaging radiopharmaceuticals 70 non porcine pancreatic 70 Provectus Pharmaceuticals specializes 70 MediGene focuses 70 anti CD3 monoclonal 70 oral picoplatin 70 ENABLE Phase 2 70 Aplidin 70 Personalized Immunotherapy 70 PDE# inhibitors 70 NPC 1C 70 FOLOTYN ® 70 CCR9 antagonist 70 monoclonal antibody therapeutics 70 targeted immunotherapies 70 RhuDex R 70 cMET 69 AcryMed technologies 69 apricitabine ATC 69 HEPLISAV TM hepatitis B 69 antiangiogenesis therapies 69 Initiates Phase II 69 candidates Azedra TM 69 hereditary emphysema 69 anticancer therapeutics 69 oral Janus kinase 69 Trastuzumab DM1 69 biased ligand 69 staphylococcal vaccine 69 relapsed leukemia 69 cosmetic cosmeceutical products 69 Albuferon albinterferon alfa 2b 69 antibody MAb 69 Angiocept 69 INS# [001] 69 diabetes irritable bowel 69 deCODE ProstateCancer TM 69 oral dihydropyrimidine dehydrogenase DPD 69 LymphoStat B TM 69 next generation URAT1 69 mertansine 69 Xcytrin R 69 isoform selective 69 immuno therapeutic 69 mda 7 69 biomarkers predictive 69 LymphoStat B belimumab 69 oral PTH 69 inflammation metabolic disorders 69 Initiates Phase III 69 commercialize SGN 69 dimebon latrepirdine 69 cardio metabolic diseases 69 Empatic ™ 69 SuperAntibody 69 Curaxin CBLC# 69 Panzem R 69 MKC# MKC# PP 69 Alessandro Riva 69 commercial bioproduction 69 selectively inhibit replication 69 OvaRex R 69 platform HDL Mimetic 69 AcryMed Incorporated 69 CMV vaccine 69 TELINTRA R 69 recombinant PSMA vaccine 69 therapeutic monoclonal antibodies 69 rxRNA 69 adecatumumab MT# 69 purinergic receptors P#X# 69 BioFocus DPI Galapagos 68 solid tumors ZYBRESTAT 68 patented DepoVax TM 68 successfully commercialize Iluvien 68 acyclovir Lauriad R 68 Adnectin 68 acetonide FA 68 Naglazyme R 68 AGS PSCA 68 anticoagulant reversing agent 68 Pruvel TM 68 ThermoDox ® clinical 68 include Healive TM 68 accumulate preferentially 68 NEUGENE R 68 Inc. AMEX YMI 68 optimal dosing regimens 68 product platforms AZX# 68 TransVax 68 Spiegelmer ® 68 engineered proteases 68 humanized monoclonal antibodies 68 Ferring Pharmaceuticals specializes 68 THR beta agonist 68 targeted radiotherapeutic 68 DNA methyltransferase inhibitors 68 Maxy G# 68 recurrent metastatic ovarian cancer 68 anti PlGF 68 ® bortezomib 68 hypoxia activated prodrug 68 Initiates Clinical Trial 68 PDE# 68 t2cure GmbH 68 Chimigen TM 68 Inotek Pharmaceuticals Corporation 68 4SC AG ISIN DE# 68 addressing idiopathic pulmonary 68 molecular biology genomics proteomics 68 Septin9 biomarker 68 ONCONASE R 68 indolent follicular non 68 INSPIRE Trial Phase III 68 molecular chaperone regulation 68 anti botulism antibody 68 biologic therapeutics 68 small molecule thrombopoietin 68 recombinant biopharmaceutical 68 optical biosensors 68 Harry Palmin President 68 Archexin 68 novel VDA molecule 68 ospemifene 68 MCSP respectively 68 commercializing anti infective 68 novel RNAi therapeutics 68 Hedgehog Pathway Inhibitor 68 Phase IIb clinical trials 68 Begins Dosing 68 MPH AMEX 68 SPL# Gel vaginal microbicide 68 CCR5 mAb 68 Nasdaq MNKD focused 68 HDL Selective Delipidation 68 GRNVAC1 68 Completes Patient Enrollment 68 staphylococcal vaccines 68 Submits Biologics License Application 68 Liprotamase 68 lead molecular radiotherapeutic 68 non nucleoside HCV 68 HGS ETR1 mapatumumab 68 TRIOLEX HE# APOPTONE HE# 68 dyslipidemia hypertension diabetes 68 PNP inhibitor 68 JAK inhibitors 68 HuCAL antibodies 68 tumor immunology 68 plasmid DNA pDNA 68 targeted anticancer biopharmaceuticals 68 RTP #i 68 IMPDH inhibitor 68 beta 1a 68 platforms GVAX 68 Ostabolin C TM 68 SIX RO ROG 68 Initiates Clinical 68 ATRA IV 68 orally administered inhibitor 68 cellular immunotherapy 68 novel immunotherapeutic 68 MSCRAMM ® 68 systemic RNAi 67 P#X# antagonist 67 targeting miR 67 include ColorectAlert TM 67 Potelligent Technology 67 GRNOPC1 contains 67 evaluating picoplatin 67 toenail onychomycosis 67 product platforms GVAX 67 Company Nasdaq RGDX 67 Zemiva TM 67 biomarker identification 67 vinorelbine tartrate 67 molecular imaging radiopharmaceutical 67 JAK2 Inhibitor 67 Tumour Vascular Disrupting Agent 67 identify protein biomarkers 67 UCB www.ucb group.com 67 Annamycin 67 Adenosine Therapeutics 67 Nasdaq LXRX biopharmaceutical 67 Ataluren 67 PORxin TM platforms 67 receptor tyrosine kinase inhibitor 67 demonstrated antitumor activity 67 romazarit 67 fibrosis IPF 67 compound ISA# 67 Vitrasert R 67 acadesine 67 commercializing novel biotherapeutics 67 psoriasis rheumatoid arthritis 67 immuno inflammatory diseases 67 Vaxfectin TM formulated 67 Hedgehog antagonist 67 Kevetrin TM 67 Phase #b/#a clinical 67 HuCNS SC ® 67 A3 adenosine receptor 67 Budesonide foam crofelemer 67 Aeolus Pharmaceuticals Announces 67 inflammatory autoimmune diseases 67 AE# vaccine 67 Presents Preclinical Data 67 Posiphen TM 67 RhuDex TM 67 alvespimycin 67 oral nucleoside analogue 67 5 HT4 67 cathepsin K inhibitor 67 Zalypsis 67 trastuzumab DM1 T DM1 67 NASH Huntington 67 neuropathic pain spasticity 67 biotherapeutic drugs 67 BioNumerik 67 Aflibercept 67 HepDirect R 67 IAP inhibitor 67 delta opioid receptor 67 drug figitumumab 67 ALN VSP Phase 67 non nucleoside inhibitor 67 agonistic human 67 ribonucleotide reductase clinically validated 67 cyclophilin inhibitors 67 treat musculoskeletal metabolic 67 Etubics 67 targeted anticancer therapies 67 AVAX AC Vaccine 67 formerly LymphoStat B 67 cladribine Cladribine Tablets 67 visit www.genenews.com 67 tiapamil 67 5 HT2A serotonin 67 TKM PLK1 67 selective angiogenic kinase inhibitor 67 IMA# 67 osteolytic bone disease 67 Please visit www.antisoma.com 67 Factor VIIa 67 Aurora kinase inhibitor 67 interferon alpha IFN 67 pafuramidine maleate 67 initiated Phase Ib 67 ASONEP TM 67 Virulizin ® 67 introduced NEUGENE 67 alpha#beta# integrin 67 SCIB1 67 Aganocide 67 investigational monoclonal antibody 67 Receives Orphan Drug 67 novel peptide 67 NeutroSpec TM 67 Tibotec BVBA 67 therapeutic peptide 67 Telik logo TELINTRA 67 HCV polymerase 67 thetreatment 67 aldehyde dehydrogenase ALDH2 deficiency 67 ImmunoGen TAP technology 67 metastatic pancreatic 67 Nasdaq MITI biopharmaceutical 67 collagen vascular 67 PSMA ADC 67 personalized immunotherapy 67 CD# CEA 67 Brussels THR 67 HIV coinfected 67 Sudhir Agrawal D.Phil 67 Fibrin MB 67 Nasdaq ONXX 67 LungAlert TM 66 refractory chronic lymphocytic 66 IMiDs R 66 rhFVIIa 66 Inc. www.micromet inc.com 66 pathophysiological effects 66 immatics 66 Onconase 66 fully liquid pentavalent 66 investigational therapies 66 BHT DNA 66 TTR amyloidosis 66 candidate custirsen 66 Tykerb lapatinib 66 subsidiaries visit http:/www.apricusbio.com 66 Insegia 66 VitiGam 66 commercializing aptamer therapeutics 66 Submits Response 66 nalbuphine ER 66 Quinamed R 66 theranostic 66 Exelixis compounds 66 Fx #A 66 Submits IND 66 PDE4 inhibitor 66 GERD migraine headaches 66 methylnaltrexone bromide 66 TRACON Pharmaceuticals 66 evaluating T DM1 66 delay bone metastases 66 Ostarine ™ 66 purified inactivated vaccine 66 psoriasis inflammatory bowel 66 R MSCRAMM 66 manufactures minimally invasive 66 lintuzumab SGN 66 R sorafenib tablets 66 InterfeRx TM 66 chimeric monoclonal antibody 66 Anidulafungin 66 estrogen receptor beta agonist 66 Fovea Pharmaceuticals subsidiary 66 haematological cancers 66 Cloretazine R 66 ELACYT 66 R Saizen R 66 CCR1 66 TBC# 66 5 lipoxygenase activating 66 prostate cancer antigen prostatic 66 TLR9 agonists 66 Romidepsin 66 Bioaccelerate compounds under 66 DCVax R 66 commercializing oxidized glutathione 66 PANVAC VF 66 PNT# 66 IMC #B 66 dasatinib Sprycel 66 constipation predominant irritable bowel 66 RAF kinase 66 novel histone deacetylase 66 Silodosin 66 ChronVac C 66 OncoVEX 66 chimeric antibody 66 infectious diseases autoimmune diseases 66 protein tyrosine phosphatase 1B 66 oral immunomodulatory 66 Ferring Pharmaceuticals privately 66 NYSE Amex AEN 66 targeting CD# 66 delivers fluocinolone acetonide FA 66 Solazed TM 66 YONDELIS 66 Veronate R 66 hepatitis C viral infection 66 class mGluR5 inhibitor 66 aurora kinase 66 adenosine A2A 66 Tectin TM 66 inflammation autoimmune diseases 66 Vaxfectin formulated 66 attach auristatin 66 XSSE OXGN 66 IMiDs ® 66 sterile lidocaine patch 66 hypercholesterolemia liver 66 evaluating satraplatin 66 orally inhaled migraine 66 Monoclonal antibody 66 visit http:/www.clinicaltrials.gov/ 66 hyaluronidase enzyme 66 abnormal p# 66 Surfaxin LS 66 Inc. Nasdaq INFI 66 Gamunex C 66 neovascular diseases 66 AN# novel 66 immunotherapeutics 66 Receives Milestone Payment 66 selective estrogen receptor modulator 66 M# rationally 66 Predictive medicine 66 MyVax ® 66 Phase lll 66 targeting PCSK9 66 Exherin TM 66 EP #R 66 MAGE A3 ASCI 66 BRAF mutant 66 Juvaris BioTherapeutics 66 Alfacell proprietary ribonuclease 66 Tovaxin TM 66 targeted antifolate 66 NASDAQ INFI 66 drug GAP #B# 66 Peyronie disease Frozen Shoulder 66 beta secretase inhibitors 66 ARRY # 66 YONDELIS R 66 ovarian cancer chronic hepatitis 66 RANK Ligand inhibitor 66 XmAb 66 ddRNAi 66 Awarded Qualifying Therapeutic 66 Therapeutic Competitors Companies 66 Homspera TM 66 novel antibody therapeutics 66 selective androgen receptor modulators 66 vidofludimus 66 sirtuin inhibitor program 66 inhibit metastasis 66 DepoVax TM 66 TOCOSOL Camptothecin 66 promising anticancer 66 virology immunology 66 human antibody therapeutics 66 TLR9 agonist IMO 66 monoclonal antibody MAb 66 KuDOS 66 Nicotine Conjugate Vaccine 66 GRN# 66 bladder ovarian 66 Proellex TM 66 tubulin inhibitor 66 AVEO integrates proprietary 66 antisense inhibitors 66 developing ACAPODENE 66 Cloretazine ® 66 recombinant hepatitis B 66 Amgen Neulasta R 66 receptor inhibiting monoclonal 66 psoriasis Crohn disease 66 aerosolized AAT 66 Rhucin ® recombinant 66 Nanobody 66 TLR7 agonist 66 candidate Trofex TM 66 tumor angiogenesis inhibitors 66 EHT AGN 66 metastatic colorectal 66 candidate TNFerade biologic 66 Strep Staph 66 multiple myeloma MM 66 Neugene 66 Martin Nicklasson CEO 66 IL-#/# 66 HepeX B TM 66 siRNA therapeutics 66 AIDS prophylaxis congestive 66 Phase 1b clinical trials 66 About Positron Positron 66 Panzem NCD 66 Vitaxin 66 skeletal sarcomere activators 66 RNAi therapeutic targeting 66 LHRH receptor positive 66 HQK 66 Cardium Therapeutics TM 66 TBC M4 66 midstage trials 66 Amgen discovers develops 66 glucose metabolic disorders 66 CEQ# 66 BrachySil TM 66 Hedgehog agonist 66 Nasdaq HALO biopharmaceutical 66 Merck OSI Pharmaceuticals 66 Albugon 66 telomerase inhibitor drug 66 immune modulating 66 sapacitabine CYC# 66 potent suppressor 66 hypereosinophilic syndrome 66 radiology peripheral vascular 65 Solazed 65 HDL Mimetic Peptide 65 ovarian prostate 65 DIFICID ™ 65 sodium thiosulfate STS 65 virosome 65 Vaxfectin R formulated 65 Fc fusion protein 65 ATL# [001] 65 Presents Preclinical 65 MVA HPV IL2 65 Vaxfectin ® 65 Oncosphere System 65 carcinoid syndrome diabetes 65 CRMD# 65 cancer immunotherapies 65 vivo toxicology 65 refractory metastatic 65 Bioral Amphotericin B 65 Syndax Pharmaceuticals Inc. 65 OMP #R# 65 HCV protease inhibitors 65 histamine dihydrochloride 65 Pruvel ™ 65 Triapine R 65 product Fentanyl TAIFUN 65 Achieves Primary Endpoint 65 Hsp# Inhibitor 65 markets Testim ® 65 vinca alkaloid 65 selective immunoproteasome inhibitor 65 Receive Milestone Payment 65 Temsirolimus 65 receiving chemoradiation therapy 65 LibiGel ® testosterone gel 65 ARIKACE ™ 65 Amigal TM 65 KRYSTEXXA TM pegloticase 65 ALN PCS 65 VEGFR2 inhibitor 65 Tesmilifene 65 EGFr expressing metastatic colorectal 65 Vincent Mutel CEO 65 dose intramuscular 65 multiple sclerosis psoriasis 65 zanolimumab 65 EVIZON TM squalamine lactate 65 systemic anaplastic large 65 lymphomas leukemias 65 motexafin gadolinium Injection 65 autologous cellular therapy 65 personalized dendritic 65 taxane derivative 65 Muraglitazar 65 DEB# 65 novel peptide therapeutics 65 immunological diseases 65 Ribavirin causes 65 novel emulsion formulation 65 NTDDS 65 inhaled AAT 65 Aviptadil 65 Phase Ib IIa 65 Pharma Merck Serono 65 doxorubicin Transdrug R 65 XL# XL# XL# XL# 65 lumiliximab 65 peptidic compound 65 BioSante Pharmaceuticals Announces 65 PAION AG ISIN 65 MOVIPREP R 65 ADAGEN 65 Proxinium TM 65 commercialize OncoGenex lead 65 TRAIL receptor antibody mapatumumab 65 Smac mimetics 65 serine protease inhibitor CU# 65 NV1FGF 65 ChronVac C R 65 Receives Approvable Letter 65 intranasal insulin product 65 anti idiotype 65 Deforolimus 65 CIMZIA r certolizumab pegol 65 OMAPRO ™ 65 Squalamine 65 alpha1 antitrypsin deficiency 65 virus HCV protease inhibitor 65 delta gamma agonist 65 nucleoside tide 65 neuronal nicotinic receptor NNR 65 Onyx Pharmaceuticals Announces 65 induced tumor regression 65 cachexia anti infectives 65 confirmatory pivotal 65 TRAIL receptor antibodies 65 CTAP# Capsules 65 CEL SCI Phase III 65 potently inhibit 65 Zemplar Capsules 65 vapreotide acetate 65 Allovectin 7 65 Initiate Clinical Trial 65 Panzem R NCD 65 Georges Gemayel 65 diseases osteoarthritis osteoporosis 65 volociximab 65 incyclinide 65 thalidomide Thalomid 65 reverse vaccinology 65 Prodarsan ® 65 NYSE Amex PBTH 65 oral JAK#/JAK# inhibitor 65 Teplizumab 65 diseases bone metastasis 65 rALLy clinical trial 65 NuMimetic TM 65 MAXY VII 65 ALK inhibitors 65 Stapled Peptide 65 primary humoral immunodeficiency 65 epothilone 65 MVA BN R 65 ERYtech 65 FTIs 65 lung pancreatic 65 potent cytotoxic 65 BCR ABL inhibitors 65 triggers apoptosis programmed 65 product AMD# 65 synthetic cannabinoid compounds 65 peptide peptide mimetic 65 polysaccharide polymer 65 Prima BioMed 65 torsemide ER 65 pathological hallmarks 65 generation URAT1 inhibitor 65 XL# XL# 65 OMP #M# 65 Captisol ® 65 PROSTVAC VF 65 mGluR2 NAM 65 PEGylated interferon 65 nephropathic cystinosis 65 Triapine 65 Receives Orphan Drug Designation 65 MCU cardiovascular 65 sarcoma melanoma 65 Daclizumab 65 bavituximab monotherapy trial 65 technology visit http:/www.genmab.com 65 products MKC# PP 65 vomiting fever headache 65 epothilones 65 hepatitis C lupus 65 TNFerade TM 65 related CMV Retinitis 65 docetaxel Taxotere R 65 essential thrombocythemia ET 65 developing Surfactant Replacement 65 Initiates Dosing 65 Micromet BiTE 65 TNF alpha selectively neutralizing 65 humanised antibody 65 NuroPro R 65 Guanilib 65 enhanced skin permeation 65 Panzem 65 hormone LHRH antagonist 65 Anticalins R 65 Sanofi Pasteur ALVAC canary 65 ATL# [002] 65 granted Ortec 65 DP VPA 65 treat chronic sinusitis 65 histone deacetylase HDAC 65 tropical parasitic 65 Ecallantide 65 resistant hormone refractory 65 specific lectin receptors 65 commercialize MDV# 65 Nereus Pharmaceuticals 65 mTOR mammalian target 65 NU# direct 65 TSX BSY 65 novel tubulin binding 65 delivery polymer matrix 65 drug conjugates ADCs 65 nano particle tumor suppressor 65 GTC recombinant form 65 HCD# [002] 65 Omacetaxine 65 mTOR inhibition 65 oral antiviral 65 International SMI SYNN 65 HyperAcute 65 proprietary PEGylation 65 factor TNF receptor 65 reslizumab 65 PER.C6 ® production 65 Oasmia 65 telomerase inhibitor 65 IgG1 monoclonal antibody 65 cystic fibrosis inflammation autoimmune 65 small molecule agonists 65 ThermoDox R 65 molecular imaging pharmaceuticals 65 SNT MC# 65 immunotoxin 65 PD2i CA Cardiac Analyzer 65 Rosetta Genomics microRNA 65 protein kinase inhibitors 65 epigenetic therapies 65 leading oral taxane 65 Combivir Kivexa 65 multicenter Phase II 65 investigational oral hepatitis C 65 non hodgkin lymphoma 65 Endotis 65 opioid tolerant adult 65 antibiotic candidate Ramoplanin 65 miRNA therapeutics 65 FoldRx Pharmaceuticals Inc. 65 CIMZIA r 65 myeloproliferative neoplasms MPNs 65 Micrologix Biotech Inc. 65 Hepatitis C Viral 65 PRESEPT study 65 Trofex 65 MEDAREX 65 Second Pivotal Phase 65 M2 subunit 65 Vertex hepatitis C 65 proteasome inhibitor 65 CVac 65 Generx TM 65 Endotoxin Activity Assay 65 SynCon 65 octreotide implant 65 http:/www.sunesis.com 65 TÎ ² 4 65 AMPK activators 65 castration resistant hormone refractory 65 syndrome overactive bladder 65 Nicole Onetto MD 65 OTC BB PVCT http:/www.pvct.com 65 Commences Phase 65 microRNA antagonists 65 Cerashield ™ 65 Sopherion 65 EVIZON ™ 65 Acute myelogenous leukemia 65 AERx R 64 intranasal formulation 64 ENMD # 64 GMX# 64 Myocet 64 please visit http:/www.vandapharma.com 64 JAK2 inhibitor 64 miRNA biomarkers 64 Panzem ® 64 Inc. Nasdaq MITI 64 structure infections ABSSSI 64 Aganocide ® 64 MVA MUC1 IL2 64 renal failure interstitial lung 64 chemosensitizer 64 lexidronam injection 64 diarrhea predominant irritable 64 Gemzar gemcitabine 64 Genentech Wyeth Pharmaceuticals 64 EGFr humanized monoclonal antibody 64 commercialize deforolimus ARIAD 64 chemistry microbiology immunology 64 Zenvia ™ 64 Hexvix ® 64 Aganocide TM 64 brivanib 64 candidate REP# 64 SNS# T 64 immunogenetics 64 Dyax logo 64 MEDA AB publ 64 Biomoda www.biomoda.com 64 Kiadis 64 proprietary biomaterials 64 oral talactoferrin 64 TransVax tm 64 Enhanze TM Technology 64 Onalta TM 64 DGAT 64 injectable collagenase 64 PrevOnco ™ 64 oncology infectious diseases 64 Corixa Corporation 64 Protexia ® 64 selective kinase inhibitors 64 Prestara 64 enhance ApoA 64 inflammatory demyelinating 64 Raf kinase inhibitor 64 MT#/MEDI-# 64 Phase IIb III 64 PDX pralatrexate 64 Miraxion Amarin lead 64 AzaSite TM 64 signal detection CTSD 64 Epratuzumab 64 thrombin component 64 autologous cellular immunotherapy 64 transformed peptic ulcer 64 Locked Nucleic Acid 64 ViaDerm hPTH #-# 64 Lucanix R 64 Galenea 64 novel L DOS# 64 MolecularBreeding 64 valtorcitabine 64 PLX MS 64 IG HCR ;) CO 64 Tovaxin ® 64 rheumatoid arthritis thrombocytopenia 64 Degarelix 64 modified glutathione analog 64 Lixivaptan 64 FUSILEV enhances 64 systemic RNA interference 64 trastuzumab Herceptin R 64 asthma rheumatoid arthritis 64 BLP# Liposome Vaccine 64 budesonide foam 64 Behcet uveitis 64 huC# DM4 64 Onalta ™ 64 Phase III ADT 64 vaginal candidiasis 64 lymphoma myeloma 64 metaglidasen 64 vaginally administered lidocaine 64 epilepsy Parkinson disease 64 pan BCR ABL 64 3 registrational trial 64 Urocidin TM 64 pipeline ImmunoGen collaborators 64 investigational humanized monoclonal antibody 64 Homspera ® 64 Dr. Aiping Young 64 factor VIIa 64 RECOTHROM ® 64 Safinamide 64 genetics immunology 64 includes TOLAMBA TM 64 NS5B polymerase 64 Verstovsek 64 NEBIDO VANTAS SUPPRELIN LA 64 fibrotic disorders 64 novel antiviral therapeutics 64 pain palliation 64 galiximab 64 JAK#/JAK# inhibitor CYT# 64 advanced compound INCB# 64 Merck Serono Nycomed 64 relapsed MM 64 Panflu TM 64 Addex Pharmaceuticals www.addexpharma.com discoverMunsif Khan spokesman 64 recombinant influenza 64 candidate CRLX# 64 Germany FSE SCH 64 AQUA ® 64 triciribine phosphate monohydrate 64 AFREZZA TM 64 Dosa suffers 64 deCODE AF TM 64 nonhuman primate model 64 deforolimus 64 Namenda Memantine HCl 64 BCG refractory carcinoma 64 orally administered pharmacological chaperones 64 glucokinase activator 64 include VALSTAR TM 64 Retisert R 64 antimitotic 64 Ceflatonin R 64 ALN HTT 64 INTEGRILIN R eptifibatide Injection 64 Epeius Biotechnologies Corporation 64 please visit http:/www.sunesis.com 64 forodesine 64 REGEN trial 64 lymphoid tumors 64 vivo pharmacology 64 www.aastrom.com 64 5 HT2A inverse 64 commercializing therapeutic 64 Epstein Barr Virus EBV 64 IMiDs ® compound 64 Hematide ™ peginesatide 64 compound INCB# 64 Bilive TM combined 64 Successfully Completes Phase 64 Crucell genetically engineered 64 CURE AF 64 Genentech sanofi aventis 64 Vegenics 64 AVEO Pharmaceuticals NASDAQ 64 Hematide ™ 64 Prochymal TM 64 initiated Phase 1b 64 Cytomegalovirus CMV 64 Oral Calcitonin 64 SAR# [002] 64 fungal infections malaria tuberculosis 64 Amgen discovers develops manufactures 64 Curaxin 64 lucinactant 64 alkylated amino acid 64 www.pranabio.com 64 Prednisone Against Refractory 64 Cotara ® 64 GATTEX TM 64 development DSC# novel 64 Quark Biotech 64 RhuDex ® 64 semi synthetic lipoglycopeptide 64 OTCBB PWRM.OB 64 Nasdaq PGNX today 64 Perflubutane Polymer Microspheres 64 taxane chemotherapy administered 64 gastrointestinal stromal tumors GISTs 64 myelofibrosis polycythemia vera 64 nucleoside analog 64 Unigene nasal calcitonin 64 Enzastaurin 64 Luveris R Ovidrel R 64 inherited retinal 64 Revimmune TM 64 p# inhibitor 64 musculoskeletal metabolic 64 SEQureDx ™ 64 RIGScan ™ 64 5 fluorouracil leucovorin 64 anti atherothrombotic 64 proprietary intranasal insulin 64 refractory Hodgkin 64 anionic backbone 64 Initiates Phase 2b 64 Fabry Disease 64 Ceflatonin 64 biliary tract cancer 64 neuro inflammatory disorders 64 LPLD 64 non personalized allogeneic 64 patented DepoVax ™ 64 topically delivered 64 ADCC enhanced 64 HCV NS3 protease 64 selective S#P# receptor agonist 64 Canvaxin TM 64 proprietary chemically modified 64 ABL inhibitor completing 64 MAb therapy